SEC Form 4/A · accession 0001572426-16-000205
Nexvet Biopharma plc · NVET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
John Bernard Payne
Director
Period of report
Jul 1, 2016
Accepted (ET)
Aug 9, 2016 · 4:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618561
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jul 1, 2016 | M | 3,600 | $0.125 | A | 7,200 | D | |
| Ordinary SharesF2 | holding | — | — | — | 6,195 | I | John B Payne Living A/C |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Share UnitsF1 | $0.125 | Jul 1, 2016 | M | 3,600 | D | Jul 1, 2016 | Jul 1, 2020 | Ordinary Shares | 3,600 | 0 | D |
Explanation of responses
- F13,600 shares were omitted from the reporting person's original Form 4, which reported the settlement of the same restricted share units reported on this amendment.
- F2The reporting person has sole voting and dispositive power with respect to these reported securities.